Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sexually Transmitted Diseases × ranpirnase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sexually Transmitted Diseases 1 Papillomavirus Infections 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Condylomata Acuminata 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

ranpirnase 1 VP-102 1 Therapies, Investigational 1 Interviews as Topic 1 Imiquimod 1 HIV Testing 1 Gels 1 Electrocoagulation 1 Colposcopy 1 Circumcision, Male 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Tamir Biotechnology, Inc.

Phase 1/2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡